Thyroid Hormone Status in Sitosterolemia is Modified by Ezetimibe

OBJECTIVES: To assess the association between biomarkers of thyroid status and 5α-stanols in sitosterolemia (STSL) patients treated with ezetimibe (EZE). STUDY DESIGN: Eight STSL patients (16-56 years) were studied during 14 weeks off EZE therapy (OFF EZE) and 14 weeks on EZE (10 mg/d; ON EZE). Seru...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Pediatr
Main Authors: Othman, Rgia A., Myrie, Semone B., Mymin, David, Roullet, Jean-Baptiste, DeBarber, Andrea E., Steiner, Robert D., Jones, Peter J.H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5572543/
https://ncbi.nlm.nih.gov/pubmed/28625503
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpeds.2017.05.049
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados